These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11342693)

  • 21. Clinical course and prognosis of trochlear nerve schwannomas.
    Elmalem VI; Younge BR; Biousse V; Leavitt JA; Moster ML; Warner J; Kupersmith MJ; Landau K; Brodsky MC; Frohman LP; May EF; Tomsak RL; Newman NJ
    Ophthalmology; 2009 Oct; 116(10):2011-6. PubMed ID: 19699532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas.
    Saito K; Kato M; Susaki N; Nagatani T; Nagasaka T; Yoshida J
    Clin Neuropathol; 2003; 22(1):30-4. PubMed ID: 12617191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trochlear nerve schwannomas occurring in patients without neurofibromatosis: case report and review of the literature.
    Santoreneos S; Hanieh A; Jorgensen RE
    Neurosurgery; 1997 Jul; 41(1):282-7. PubMed ID: 9218320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual case of multiple cellular and malignant schwannomas of the cranial and spinal nerves.
    Suresh TN; Mahadevan A; Chandrashekhar Sagar B; Santosh V; Yasha TC; Shankar SK
    Clin Neuropathol; 2003; 22(1):23-9. PubMed ID: 12617190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibromatosis type 2.
    Slattery WH
    Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of outcomes of peripheral nerve schwannoma excision in neurofibromatosis type 2 patients and non-neurofibromatosis type 2 patients: A case control study.
    Bendon CL; Furniss D; Giele HP
    J Plast Reconstr Aesthet Surg; 2015 Sep; 68(9):1199-203. PubMed ID: 26139580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contiguous conventional and plexiform schwannomas. Report of two cases.
    White JB; Scheithauer BW; Amrami KK; Babovic-Vuksanovic D; Spinner RJ
    J Neurosurg; 2006 Feb; 104(2):319-24. PubMed ID: 16509508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
    Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
    J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
    Ziadi A; Saliba I
    Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric eighth cranial nerve schwannoma without evidence of neurofibromatosis.
    Mendel RC; Brumback RA; Leech RW; Van Campen LE; Wilson DA; Britton BH; Carter LP
    J Child Neurol; 1999 Jan; 14(1):67-9. PubMed ID: 10025539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.
    Goutagny S; Raymond E; Esposito-Farese M; Trunet S; Mawrin C; Bernardeschi D; Larroque B; Sterkers O; Giovannini M; Kalamarides M
    J Neurooncol; 2015 Apr; 122(2):313-20. PubMed ID: 25567352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type II neurofibromatosis presenting as quadriceps atrophy.
    Grazzi L; Chiapparini L; Parati EA; Giombini S; D'Amico D; Leone M; Bussone G
    Ital J Neurol Sci; 1998 Apr; 19(2):94-6. PubMed ID: 10935844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2.
    Messerli SM; Prabhakar S; Tang Y; Mahmood U; Giovannini M; Weissleder R; Bronson R; Martuza R; Rabkin S; Breakefield XO
    Hum Gene Ther; 2006 Jan; 17(1):20-30. PubMed ID: 16409122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
    Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
    J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intracranial and intramedullary peripheral nerve sheath tumours. Case reports from 20 autopsies].
    Aguirre-Quezada DE; Martínez-Anda JJ; Aguilar-Ayala EL; Chávez-Macías L; Olvera-Rabiela JE
    Rev Neurol; 2006 Aug 16-31; 43(4):197-200. PubMed ID: 16883507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ocular presentation of neurofibromatosis 2.
    Ragge NK; Baser ME; Riccardi VM; Falk RE
    Eye (Lond); 1997; 11 ( Pt 1)():12-8. PubMed ID: 9246269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.
    Picry A; Bonne NX; Ding J; Aboukais R; Lejeune JP; Baroncini M; Dubrulle F; Vincent C
    Laryngoscope; 2016 Oct; 126(10):2358-62. PubMed ID: 27075822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Audiologic presentation of vestibular schwannomas in neurofibromatosis type 2.
    Lalwani AK; Abaza MM; Makariou EV; Armstrong M
    Am J Otol; 1998 May; 19(3):352-7. PubMed ID: 9596188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic image (252). A woman with complaints of tinnitus, hearing loss and headache].
    te Lintelo MP; Koehler PJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2565. PubMed ID: 16320667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromatosis 2 in the pediatric population.
    Nunes F; MacCollin M
    J Child Neurol; 2003 Oct; 18(10):718-24. PubMed ID: 14649556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.